American Society of Clinical Oncology, 35th Annual Meeting SummariesJOHNSON, David H.Journal of clinical oncology. 1999, issn 0732-183X, 91 p., NSConference Proceedings

Evarts A. Graham and the First Pneumonectomy for Lung CancerHORN, Leora; JOHNSON, David H.Journal of clinical oncology. 2008, Vol 26, Num 19, pp 3268-3275, issn 0732-183X, 8 p.Article

A Comparative Multifield FEA and Experimental Study on the Enhanced Manufacturability of 6061-T6511 Aluminum Using dc CurrentKHALILOLLAHI, Amir; JOHNSON, David H; ROTH, John T et al.Journal of manufacturing science and engineering. 2009, Vol 131, Num 6, issn 1087-1357, 064503.1-064503.5Article

Treatment and outcomes for elderly patients with small cell lung cancerSTEPHENS, Richard J; JOHNSON, David H.Drugs & aging. 2000, Vol 17, Num 3, pp 229-247, issn 1170-229XArticle

Surgery for early stage non-small cell lung cancerFEINS, R. H.Seminars in oncology. 1997, Vol 24, Num 4, pp 419-422, issn 0093-7754Article

Combined modality therapy of non-small cell lung cancerRUCKDESCHEL, J. C.Seminars in oncology. 1997, Vol 24, Num 4, pp 429-439, issn 0093-7754Article

Small cell lung cancer in the elderly patientJOHNSON, D. H.Seminars in oncology. 1997, Vol 24, Num 4, pp 484-491, issn 0093-7754Article

The biology of lung cancerCARBONE, D. P.Seminars in oncology. 1997, Vol 24, Num 4, pp 388-401, issn 0093-7754Article

Lung cancer chemoprevention and management of carcinoma in situKARP, D. D.Seminars in oncology. 1997, Vol 24, Num 4, pp 402-410, issn 0093-7754Article

Targeted therapies in the treatment of lung cancerBUNN, Paul A; JOHNSON, David H.Seminars in oncology. 2002, Vol 29, Num 1, issn 0093-7754, 154 p., SUP4Serial Issue

Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancerBONOMI, Philip.Seminars in oncology. 2002, Vol 29, Num 1, pp 78-86, issn 0093-7754, SUP4Article

Current management of small cell lung cancerSANDLER, A. B.Seminars in oncology. 1997, Vol 24, Num 4, pp 463-476, issn 0093-7754Article

Lung cancerJOHNSON, David H; SHEPHERD, Frances A; BOSL, G et al.Journal of clinical oncology. 2005, Vol 23, Num 14, issn 0732-183X, 124 p.Serial Issue

Radiation therapy in the management of patients with unresectable stage IIIA and IIIB non-small cell lung cancerWAGNER, H. JR.Seminars in oncology. 1997, Vol 24, Num 4, pp 423-428, issn 0093-7754Article

A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non - Small Cell Lung CancerMUTTER, Robert; BO LU; CHOY, Hak et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2158-2165, issn 1078-0432, 8 p.Article

Coupled Multifield Finite Element Analysis Model of Upsetting Under an Applied Direct CurrentKRONENBERGER, Thomas J; JOHNSON, David H; ROTH, John T et al.Journal of manufacturing science and engineering. 2009, Vol 131, Num 3, issn 1087-1357, 031003.1-031003.8Article

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialALBAIN, Kathy S; SUZANNE SWANN, R; FY, Willard A et al.Lancet (British edition). 2009, Vol 374, Num 9687, pp 379-386, issn 0140-6736, 8 p.Article

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to ErlotinibMILLER, Vincent A; RIELY, Gregory J; HERBST, Roy S et al.Journal of clinical oncology. 2008, Vol 26, Num 9, pp 1472-1478, issn 0732-183X, 7 p.Article

Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non-Small-Cell Lung Cancer : Results From a Randomized Trial, JBR.10BEZJAK, Andrea; LEE, Christopher W; SHEPHERD, Frances A et al.Journal of clinical oncology. 2008, Vol 26, Num 31, pp 5052-5059, issn 0732-183X, 8 p.Article

Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in eastern cooperative oncology group performance status 2 non-small-cell lung cancer patients : ECOG 1599LANGER, Corey; SIGUI LI; SCHILLER, Joan et al.Journal of clinical oncology. 2007, Vol 25, Num 4, pp 418-423, issn 0732-183X, 6 p.Article

Changes in the natural history of nonsmall cell lung cancer (NSCLC)- : Comparison of outcomes and characteristics in patients with advanced NSCLC entered in eastern cooperative oncology group trials before and after 1990WAKELEE, Heather A; BERNARDO, Patricia; JOHNSON, David H et al.Cancer. 2006, Vol 106, Num 10, pp 2208-2217, issn 0008-543X, 10 p.Article

Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-lnducible factor-1α in non-small cell lung cancerCSIKI, Ildiko; YANAGISAWA, Kiyoshi; HARUKI, Nobuhiro et al.Cancer research (Baltimore). 2006, Vol 66, Num 1, pp 143-150, issn 0008-5472, 8 p.Article

Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancerCAO, Carolyn; ALBERT, Jeffrey M; LING GENG et al.Cancer research (Baltimore). 2006, Vol 66, Num 23, pp 11409-11415, issn 0008-5472, 7 p.Article

Lung cancer in womenPATEL, Jyoti D.Journal of clinical oncology. 2005, Vol 23, Num 14, pp 3212-3218, issn 0732-183X, 7 p.Article

Page / 8